Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d96d96d810c5b837821358e2912caee5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a4783407e23a20dbe43d383a5d0fcb5 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-94 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517 |
filingDate |
2007-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2013-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e569aa77826fe98a8f20309cd6d289c4 |
publicationDate |
2013-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8372856-B2 |
titleOfInvention |
Hydrates of erlotinib hydrochloride |
abstract |
Erlotinib hydrochloride hydrate is formed from an aqueous solution and is useful as a pharmaceutical and as a purification intermediate. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9593083-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015299141-A1 |
priorityDate |
2006-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |